After the successful launch of our Natural Compounds Special Interest Group last year we are running our second event in collaboration with Neem Biotech, the Medicines Discovery Catapult and Innovate UK.
The focus of these Special Interest Groups will be on taking natural compounds that have already been identified and for which research data already exists, to market. The group will share advice on developing routes to market, managing regulatory requirements, achieving relevant product certifications and running clinical trials.
Draft Programme
9-9:30 Registration
Gwyn Tudor, CEO, MediWales
Michael Graz, Managing Director, Neem Biotech
Heike Stier, Senior Consultant, Strategic Consulting & Innovation, analyse & realise
Chris Molloy, CEO, Medicines Discovery Catapult
11-11:30 Break
Katie Beckett, Enforcement Team Leader, Department for Business, Energy and Industrial Strategy
Company showcase:
Andrew Gallagher, Chief Operating Officer, Phynova Group
New from old: transforming traditional Chinese medicine into modern healthcare products
Ross Burn, Co-Founder & Managing Director, CatSci
Robert Nash, CEO, PhytoQuest
Further showcase spaces available
12:45-13:45 Lunch
Innovate UK/KTN
Simon Haslam, Senior Associate, Abel and Imray
Academic Showcase
Andrew Thomas, Principal Lecturer, Cardiff Metropolitan University
Dr Geertje Van Keulen, Associate Professor, Swansea University Medical School
Exploring ancient Welsh texts for antimicrobials
Alex White, Pharmacy Programme Director, Cardiff University School of Pharmacy
Further showcase spaces available
16:00 Close
This event is free to attend; to find out more information or register your place please click here.
There are also a few exhibition stands available, please contact Isabelle if you would like to find out more.